Loading stock data…
$23.98+1.04 (+4.53%)
SpyGlass Pharma, Inc.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), which comprises novel ...
MongoDB downgraded, Block upgraded: Wall Street's top analyst calls
Health care stocks rose late Friday afternoon, with the NYSE Health Care Index and the State Street
Health care stocks rose Friday afternoon, with the NYSE Health Care Index increasing 1.3% and the St